China's Voids Patent for Gilead Sciences, Inc.'s Viread

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! by Richard Daverman, PhD July 30, 2013 -- China's State Intellectual Property Office has invalidated the patent for Viread, a treatment for hepatitis B and HIV/AIDS developed by Gilead Sciences.

http://www.biospace.com/news_story.aspx?StoryID=304259&full=1